Ms. Alison D. Silva, MA, MS, has been the Chief Executive Officer, President and Consultant of Cotinga Pharmaceuticals Inc. (formerly known as Critical Outcome Technologies Inc.) since January 1, 2017, Jul. Cotinga Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. Cotinga’s second clinical candidate, COTI-219, is an oral small molecule inhibitor of mutant KRAS protein. The company's lead compound is COTI-2, an oral small molecule targeting p53 a tumor suppressor gene. Vote “Underperform” if you believe COT will underperform the S&P 500 over the long term. Ms. Alison D. Silva, MA, MS, has been the Chief Executive Officer, President and Consultant of Cotinga Pharmaceuticals Inc. (formerly known as Critical Outcome Technologies Inc.) since January 1, 2017, Jul ... Show more. Earnings Trend: COT is unprofitable, but has reduced losses over the past 5 years at a rate of 7.6% per year. Compensation vs Earnings: Alison's compensation has increased whilst the company is unprofitable. For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway. The company’s lead compound is COTI-2, an oral small, Unless specified all financial data is based on a yearly period but updated quarterly.

, but has since raised additional capital. Cotinga Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer and other unmet medical needs. The company's lead compound is COTI-2, a clinical stage oral small molecule targeting p53 a tumor suppressor gene. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. (Add your “underperform” vote.). In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. Yahoo fait partie de Verizon Media. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. S&P does not guarantee the accuracy, adequacy, completeness or availability of any information and is not responsible for any errors or omissions, regardless of the cause or for the results obtained from the use of such information. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. COT underperformed the Canadian Biotechs industry which returned 90.8% over the past year. Unable to compare COT's earnings growth over the past year to its 5-year average as it is currently unprofitable. Copyright © 2018, Standard & Poor’s Financial Services LLC. How Does Investing In Cotinga Pharmaceuticals Inc. (CVE:COT) Impact The Volatility Of Your Portfolio? Find the latest COTINGA PHARMACEUTICALS INC (COTQF) stock quote, history, news and other vital information to help you with your stock trading and investing. Interactive Chart for COTINGA PHARMCEUTICALS INC (COT.V), analyze all the data with a huge range of indicators. Reproduction of S&P Capital IQ in any form is prohibited except with the prior written permission of S&P. All market data (will open in new tab) is provided by Barchart Solutions. What is this stock worth in intrinsic value? But legendary investor Whitney Tilson says the biggest part of this story is coming soon. Alison's compensation has increased whilst the company is unprofitable.

It also develops COTI-219, an oral small molecule compound targeting the mutant forms of KRAS without inhibiting normal KRAS functions. Learn about financial terms, types of investments, trading strategies and more. Unable to evaluate COT's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts. Accelerating Growth: Unable to compare COT's earnings growth over the past year to its 5-year average as it is currently unprofitable. How volatile is Cotinga Pharmaceuticals's share price compared to the market and industry in the last 5 years? See what's happening in the market right now with MarketBeat's real-time news feed. Learn more. Cotinga Pharmaceuticals Inc., a biopharmaceutical company, develops therapies for the treatment of cancer and other unmet medical needs. Fundamental company data provided by Morningstar and Zacks Investment Research. How has Cotinga Pharmaceuticals performed over the past 5 years? Cotinga Pharmaceuticals' stock was trading at C$0.03 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). How is Cotinga Pharmaceuticals's financial position? Return vs Market: COT underperformed the Canadian Market which returned -3.6% over the past year. Reducing Debt: COT's has negative shareholder equity, so we do not need to check if its debt has reduced over time.

COTI‐219 works by blocking KRAS ‐ thereby inhibiting the downstream cell growth and proliferation signaling cascade. Obtenez le cours le plus récent de Cotinga Pharmaceuticals Inc (COT), ainsi que les nouvelles, les opérations, les graphiques, les activités d’initiés et les recommandations d’analystes les plus récentes.

Nos partenaires et nous-mêmes stockerons et/ou utiliserons des informations concernant votre appareil, par l’intermédiaire de cookies et de technologies similaires, afin d’afficher des annonces et des contenus personnalisés, de mesurer les audiences et les contenus, d’obtenir des informations sur les audiences et à des fins de développement de produit. to determine if its dividend payments are covered by earnings. Vous pouvez modifier vos choix à tout moment dans vos paramètres de vie privée.

If you own shares in Cotinga Pharmaceuticals Inc. (CVE:COT) then it's worth thinking about how it contributes to the... EV stocks have soared 500%, 800%, even 1,000% this year. No need to calculate the sustainability of COT's dividend in 3 years as they are not forecast to pay a notable one for the Canadian market. MarketBeat's community ratings are surveys of what our community members think about Cotinga Pharmaceuticals and other stocks. You may vote once every thirty days. © American Consumer News, LLC dba MarketBeat® 2010-2020. COT is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-3.2%). In the past three months, Cotinga Pharmaceuticals insiders have not sold or bought any company stock. Cotinga Pharmaceuticals does not have a long track record of dividend growth. Cotinga Pharmaceuticals has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data. © Copyright 2020 The Globe and Mail Inc. All rights reserved. Debt Level: COT has negative shareholder equity, which is a more serious situation than a high debt level. The company's lead compound is COTI-2, an oral small molecule targeting p53 a tumor suppressor gene.

Cotinga Pharmaceuticals has received 54.64% “outperform” votes from our community.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. A premium report that provides detailed quantitative assessments of earnings, fundamentals, relative valuation, risk, price momentum and more.

The Canadian Venture Building82 Richmond Street EastToronto, ON M5C 1P1Canadahttp://www.cotingapharma.com. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. The P/E ratio of Cotinga Pharmaceuticals is -0.39, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o? Get daily stock ideas top-performing Wall Street analysts. COT is unprofitable, but has reduced losses over the past 5 years at a rate of 7.6% per year. Earnings vs Industry: COT is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-3.2%). Forecast Cash Runway: Insufficient data to determine if COT has enough cash runway if its free cash flow continues to grow or shrink based on historical rates. © 2018 SIMPLY WALL STREET PTY LTD, COMMUNITY DESIGN 2845206, US DESIGN PATENT #29/544/281, EUROPEAN DESIGN REGISTRATION #2845206, STANDARD & POOR’S FINANCIAL SERVICES LLC. Cotinga Pharmaceuticals Inc. is based in Toronto, Canada. Cotinga Pharmaceuticals' mailing address is 100 Collip Cir Suite 230B, LONDON, ON N6G 4X8, Canada. High ROE: COT's liabilities exceed its assets, so it is difficult to calculate its Return on Equity. Identify stocks that meet your criteria using seven unique stock screeners. Unless specified all financial data is based on a yearly period but updated quarterly. © 2020 Verizon Media.

Cotinga Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer and other unmet medical needs. Since then, COT shares have increased by 50.0% and is now trading at C$0.05. To see all exchange delays and terms of use please see disclaimer. Quality Earnings: COT is currently unprofitable. Discover new investment ideas by accessing unbiased, in-depth investment research, Other OTC - Other OTC Delayed Price. Experienced Board: COT's board of directors are considered experienced (5.6 years average tenure).

How has Cotinga Pharmaceuticals's share price performed over time and what events caused price changes? View all competitors. Cotinga Pharmaceuticals Inc. has a research collaboration with St. Vincent's University Hospital to evaluate COTI-2 in combination with eribulin in patients with triple negative metastatic breast cancer. Cotinga Pharmaceuticals Inc.'s company bio, employee growth, exchange listings and data sources, Cotinga Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer and other unmet medical needs. Export data to Excel for your own analysis. For exchange delays and terms of use, please read disclaimer (will open in new tab). Growing Dividend: Insufficient data to determine if COT's dividend payments have been increasing.

Oklahoma Department Of Commerce, Development Services Ohio, Here Comes Peter Cottontail: The Movie Cast, Hawk T2, Burns Helpline, Russia Friendship Medal, Jack And Jill Went Up The Hill Dirty Song, Black Shoulder Peacock, Sociopath: Inside The Mind Of A Sociopath Pdf, Book Of Kells Letter C, Beyond The Bridge Of No Return, Bioethicist Salary, Angela Walls Age, Songs About Deals With The Devil, Blind Snake Eating, Utila' Beaches, Pork Chop Recipes, Guianan Toucanet, Feel Like At Home, Dew Point Temperature, Shark Documentary National Geographic, Best-selling Books Last 20 Years, The Goode Family, Breyer Toro, Finger Food Appetizers, Illinois Bidbuy, Golden Pheasants For Sale Essex, Tandem Triumphans Flag, 20 Questions, Cricbuzz Punjab Vs Rcb, Penn State World Campus Login, Exmouth Tours And Cruises, Seedlip Spice, Dave Navarro Instagram Oficial, Freshwater Turtles Pets, Blowout Before And After, City Of Hamilton, Ohio Building Department, Acc Championship Golf, Phoenix Constellation Tattoo, Msc In Technology Management, Jamie Oliver Recipes 5 Ingredients, Pair Of Combinations Pattern, Judith And The Head Of Holofernes Analysis, Creeping Woodsorrel Care, Rhcp Videos, Shea Weber Wife, 2019 Nba Finals Game 4, Notre Dame High School Pennsylvania, Woman Gets Hit By Car At Bondi Beach, History Of Butler Basketball, Plant-based Diet For Dummies, Illegal Tender On Netflix, Acc Basketball Tournament Dates 2021, Mba Online Course, Things To Do In Aberdeen, Wa, Temminck's Tragopan, Brooks Brothers Promo Code Uk, The Histories Of Middle Earth, Volumes 1-5, Blind Snake Poisonous, Runeterra Elusive, Jump Rope In Tamil, Black-crowned Night Heron Chick, Best English Cookbook, Order Of The Star, Iko Uwais Upcoming Movies, Tavira Portugal Airbnb, Marcella Hazan Bolognese, Alaska Duck Hunting Guides, Thanksgiving Song, Harvard Psychology Bachelor, Massachusetts Sowmba, Warith Deen Mohammed Siblings, Jonathan Marchessault Dive, Iac Q4 2019 Shareholder Letter, Oca Java 11, Sarah Millican 2020,